Cramer's lightning round: BioXcel Therapeutics may be home run or nothing

4D Molecular Therapeutics Inc: “Regeneron is the horse to bet on, because it’s been a great investment.”

SoFi Technologies Inc: “I do believe it’s bottoming, but I don’t know what gets it higher.”

BioXcel Therapeutics Inc: “It may be home run or nothing, and that’s always tough.”

Veru Inc: “The test for [the company’s Covid treatment pill] … The FDA staff didn’t seem to like it.”

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.

Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money Twitter – Jim Cramer Twitter – Facebook – Instagram

Questions, comments, suggestions for the “Mad Money” website? madcap@cnbc.com

This article was originally published by Cnbc.com. Read the original article here.